Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study
- PMID: 22404725
- PMCID: PMC3636529
- DOI: 10.1111/j.1365-2893.2011.01545.x
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study
Abstract
Hepatitis C virus (HCV) infection is associated with systemic inflammation and metabolic complications that might predispose patients to atherosclerosis. However, it remains unclear if HCV infection increases the risk of acute myocardial infarction (MI). To determine whether HCV infection is an independent risk factor for acute MI among adults followed in general practices in the United Kingdom (UK), a retrospective cohort study was conducted in The Health Improvement Network, from 1996 through 2008. Patients ≥18 years of age with at least 6 months of follow-up and without a prior history of MI were eligible for study inclusion. HCV-infected individuals, identified with previously validated HCV diagnostic codes (n = 4809), were matched on age, sex and practice with up to 15 randomly selected patients without HCV (n = 71 668). Rates of incident MI among patients with and without a diagnosis of HCV infection were calculated. Adjusted hazard ratios were estimated using Cox proportional hazards regression, controlling for established cardiovascular risk factors. During a median follow-up of 3.2 years, there was no difference in the incidence rates of MI between HCV-infected and -uninfected patients (1.02 vs 0.92 events per 1000 person-years; P = 0.7). HCV infection was not associated with an increased risk of incident MI (adjusted HR, 1.10; 95% confidence interval [CI], 0.67-1.83). Sensitivity analyses including the exploration of a composite outcome of acute MI and coronary interventions yielded similar results (adjusted HR, 1.16; 95% CI, 0.77-1.74). In conclusion, HCV infection was not associated with an increased risk of incident MI.
© 2011 Blackwell Publishing Ltd.
Conflict of interest statement
Declaration of Personal Interests: The authors have no conflicts of interest to disclose.
Similar articles
-
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.Hepatology. 2012 Nov;56(5):1688-98. doi: 10.1002/hep.25866. Epub 2012 Oct 14. Hepatology. 2012. PMID: 22619086 Free PMC article.
-
Hepatitis C Virus Infection Associated With an Increased Risk of Deep Vein Thrombosis: A Population-Based Cohort Study.Medicine (Baltimore). 2015 Sep;94(38):e1585. doi: 10.1097/MD.0000000000001585. Medicine (Baltimore). 2015. PMID: 26402820 Free PMC article.
-
Association Between Chronic Hepatitis C Virus Infection and Myocardial Infarction Among People Living With HIV in the United States.Am J Epidemiol. 2020 Jun 1;189(6):554-563. doi: 10.1093/aje/kwz236. Am J Epidemiol. 2020. PMID: 31712804 Free PMC article.
-
Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction.Heart. 2020 Jun;106(12):916-922. doi: 10.1136/heartjnl-2019-315511. Epub 2020 Feb 29. Heart. 2020. PMID: 32114515 Free PMC article.
-
Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.Dig Dis Sci. 2014 Jul;59(7):1586-93. doi: 10.1007/s10620-014-3222-3. Epub 2014 Jun 4. Dig Dis Sci. 2014. PMID: 24894512 Review.
Cited by
-
Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States.Pharmacoepidemiol Drug Saf. 2023 Oct;32(10):1142-1151. doi: 10.1002/pds.5651. Epub 2023 Jun 15. Pharmacoepidemiol Drug Saf. 2023. PMID: 37278688 Free PMC article.
-
Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection.J Am Heart Assoc. 2022 Oct 4;11(19):e026473. doi: 10.1161/JAHA.122.026473. Epub 2022 Sep 21. J Am Heart Assoc. 2022. PMID: 36129038 Free PMC article.
-
Association of hepatitis C infection and acute coronary syndrome: A case-control study.Medicine (Baltimore). 2021 May 28;100(21):e26033. doi: 10.1097/MD.0000000000026033. Medicine (Baltimore). 2021. PMID: 34032724 Free PMC article.
-
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond.World J Gastroenterol. 2021 May 7;27(17):1959-1972. doi: 10.3748/wjg.v27.i17.1959. World J Gastroenterol. 2021. PMID: 34007133 Free PMC article. Review.
-
Cardiovascular risk assessment by electrocardiographic Holter monitoring in patients with chronic hepatitis C.Arch Med Sci. 2020 Jul 15;16(5):1031-1039. doi: 10.5114/aoms.2020.96600. eCollection 2020. Arch Med Sci. 2020. PMID: 32863991 Free PMC article.
References
-
- Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705–714. - PubMed
-
- Balogun MA, Ramsay ME, Hesketh LM, et al. The prevalence of hepatitis C in England and Wales. J Infect. 2002;45(4):219–226. - PubMed
-
- Lauer GM, Walker BD. Hepatitis C virus infection. The New England journal of medicine. 2001;345(1):41–52. - PubMed
-
- Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. The New England journal of medicine. 1999;341(8):556–562. - PubMed
-
- National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10–12, 2002. Hepatology (Baltimore, Md. 2002;36(5 Suppl 1):S3–S20. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
